Irene Louise Topp, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 211 Topp's Rd, Sagle, ID 83860 Phone: 208-946-6059 |
News Archive
Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon beta-1a IM) reported significantly fewer injection site reactions (ISRs) compared to patients on Betaferon- (interferon beta-1b), Copaxone- (glatiramer Acetate) or Rebif - (interferon beta-1a).
In today's health policy headlines, the Supreme Court added 30 minutes to the time allocation for next month's health law arguments. Also in the news, the federal government announced funding awards yesterday to help launch consumer-governed health plans in eight states.
pSivida Limited has announced that current data from its lead cancer product BrachySil will be presented at this year's European Society for Therapeutic and Radiation Oncology Conference in Budapest on May 5, 2005. The conference is an opportunity to share and validate the Company's promising findings with an international scientific, clinical and industrial audience.
The first results from The Irish Longitudinal Study on Ageing, a national study of 8,000 older people aged 50 and over in Ireland, were launched this week by the Minister for Health and Children, Dr James Reilly.
Ahead of World Malaria Day on April 25, the U.N. General Assembly on Monday adopted a resolution urging governments, U.N. agencies, nongovernmental organizations (NGOs), and private foundations to accelerate their efforts and build upon established successes in the fight against the disease, particularly in Africa, Deutsche Presse-Agentur/M&C reports.
› Verified 3 days ago